Anastasia Serafimovska1, Jia Liu2,3, Jane Beith1,4,5, Phyllis Butow1. 1. Psycho-Oncology Co-Operative Group (PoCoG), University of Sydney, Sydney, NSW, Australia. 2. ProCan, The Children's Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, Sydney, NSW, Australia. jia.liu@sydney.edu.au. 3. Faculty of Medicine, University of Western Sydney, Campbelltown, NSW, Australia. jia.liu@sydney.edu.au. 4. Chris O'Brien Lifehouse, Sydney, NSW, Australia. 5. University of Sydney, Sydney, NSW, Australia.
Abstract
PURPOSE: Despite strong demand from breast cancer survivors, there is a dearth of flexibly delivered, accessible psychological interventions addressing fear of cancer recurrence (FCR). This study aimed to explore patients' and clinicians' perspectives concerning the experience, utility and barriers to a novel clinician-led FCR intervention (CIFeR). METHODS: Twenty female participants (mean age, 59.8, SD = 11.43), diagnosed with early-stage breast cancer (mean years since diagnosis = 2.8, SD = 1.37 years) participated in telephone interviews, and their five oncologists completed a semi-structured electronic survey. Thematic qualitative analyses were performed on interview transcripts and survey responses. RESULTS: Findings indicated both patients and clinicians were positive about CIFeR with perceived cognitive, behavioural and emotional benefits of CIFeR most pronounced for patients with clinically significant FCR. All patients, however, found that receiving CIFeR (especially the tailored prognostic information) from their oncologists with whom they had a long-standing relationship added a much-needed human element to addressing FCR. Similarly, clinicians valued CIFeR as a clear and consistent way to address unmet needs around FCR, with some barriers around time, language and cultural issues noted. CONCLUSION: Overall, all participants perceived CIFeR as strongly beneficial in reducing FCR and related worries, thus warranting further evaluation of its utility in clinical practice.
PURPOSE: Despite strong demand from breast cancer survivors, there is a dearth of flexibly delivered, accessible psychological interventions addressing fear of cancer recurrence (FCR). This study aimed to explore patients' and clinicians' perspectives concerning the experience, utility and barriers to a novel clinician-led FCR intervention (CIFeR). METHODS: Twenty female participants (mean age, 59.8, SD = 11.43), diagnosed with early-stage breast cancer (mean years since diagnosis = 2.8, SD = 1.37 years) participated in telephone interviews, and their five oncologists completed a semi-structured electronic survey. Thematic qualitative analyses were performed on interview transcripts and survey responses. RESULTS: Findings indicated both patients and clinicians were positive about CIFeR with perceived cognitive, behavioural and emotional benefits of CIFeR most pronounced for patients with clinically significant FCR. All patients, however, found that receiving CIFeR (especially the tailored prognostic information) from their oncologists with whom they had a long-standing relationship added a much-needed human element to addressing FCR. Similarly, clinicians valued CIFeR as a clear and consistent way to address unmet needs around FCR, with some barriers around time, language and cultural issues noted. CONCLUSION: Overall, all participants perceived CIFeR as strongly beneficial in reducing FCR and related worries, thus warranting further evaluation of its utility in clinical practice.
Entities:
Keywords:
Fear of cancer recurrence; Novel; Oncologist-led intervention; Psycho-oncology; Stepped care; Supportive care
Authors: Kerri-Anne R Mitchell; Kelly J Brassil; Serena A Rodriguez; Edward Tsai; Kayo Fujimoto; Kate J Krause; L Aubree Shay; Andrew E Springer Journal: Psychooncology Date: 2020-08-23 Impact factor: 3.894
Authors: Luigi Grassi; Juan E Mezzich; Maria Giulia Nanni; Michelle B Riba; Silvana Sabato; Rosangela Caruso Journal: Int Rev Psychiatry Date: 2017-08-07
Authors: B Thewes; P Butow; M L Bell; J Beith; R Stuart-Harris; M Grossi; A Capp; D Dalley Journal: Support Care Cancer Date: 2012-02-11 Impact factor: 3.603
Authors: Nina M Tauber; Mia S O'Toole; Andreas Dinkel; Jacqueline Galica; Gerry Humphris; Sophie Lebel; Christine Maheu; Gozde Ozakinci; Judith Prins; Louise Sharpe; Allan Ben Smith; Belinda Thewes; Sébastien Simard; Robert Zachariae Journal: J Clin Oncol Date: 2019-09-18 Impact factor: 44.544
Authors: Anna Hauffman; Sven Alfonsson; Anna Bill-Axelson; Leif Bergkvist; Marina Forslund; Susanne Mattsson; Louise von Essen; Peter Nygren; Helena Igelström; Birgitta Johansson Journal: Psychooncology Date: 2020-09-22 Impact factor: 3.894